CRON logo

Cronos Group Inc. Stock Price

TSX:CRON Community·CA$1.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CRON Share Price Performance

CA$4.32
0.82 (23.43%)
​
CA$4.68
Fair Value
CA$4.32
0.82 (23.43%)
7.6% undervalued intrinsic discount
CA$4.68
Fair Value
Price CA$4.32
AnalystConsensusTarget CA$4.68
AnalystLowTarget CA$3.45
AnalystHighTarget CA$6.00

CRON Community Narratives

Fair Value
·
Fair Value CA$4.68 7.6% undervalued intrinsic discount

GrowCo Capacity And Global Markets Will Unlock Potential

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
Fair Value
·
Fair Value CA$3.45 25.2% overvalued intrinsic discount

Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Fair Value
·
Fair Value CA$6 28.0% undervalued intrinsic discount

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CRON logo
Cronos Group
28.0% undervalued intrinsic discount

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

View narrative
Updated 9 Aug
Read Narrative
CRON logo
Cronos Group
7.6% undervalued intrinsic discount

GrowCo Capacity And Global Markets Will Unlock Potential

View narrative
Updated 14 Jun
Read Narrative
CRON logo
Cronos Group
25.2% overvalued intrinsic discount

Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth

View narrative
Updated 31 May
Read Narrative

Trending Discussion

No trending discussion available.

Updated Narratives

CRON logo

CRON: Buybacks And Higher Multiple Will Support A Stronger Outlook

Fair Value: CA$6 28.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

CRON: Brand Strength And Rescheduling Tailwinds Will Support Future Upside

Fair Value: CA$4.68 7.6% undervalued intrinsic discount
10 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

CRON: Partial Rescheduling Expectations Will Constrain Future Earnings Power

Fair Value: CA$3.45 25.2% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
3 Rewards
View Full Analysis

Cronos Group Inc. Key Details

US$179.1m

Revenue

US$102.1m

Cost of Revenue

US$77.0m

Gross Profit

US$7.1m

Other Expenses

US$70.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.19
43.02%
39.08%
0%
View Full Analysis

About CRON

Founded
n/a
Employees
610
CEO
Michael Gorenstein
WebsiteView website
thecronosgroup.com

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Recent CRON News & Updates

Narrative Update • Aug 09

CRON: Buybacks And Higher Multiple Will Support A Stronger Outlook

Analysts have increased their Cronos Group price target by CA$1 to CA$6, reflecting updated assumptions regarding fair value, discount rate, growth, and margins following recent research updates. What’s in the News for Cronos Group Cronos Group announced a share repurchase program that allows the company to buy back up to 18,712,918 shares for $50 million.

Recent updates

No updates

Cronos Group Inc. Competitors

APTX logo

Apotex Health

Symbol: TSX:APTX
Market cap: CA$8.1b
CURA logo

Curaleaf Holdings

Symbol: TSX:CURA
Market cap: CA$3.5b
GTII logo

Green Thumb Industries

Symbol: CNSX:GTII
Market cap: CA$2.2b
View more competitors